Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04097704 · ClinicalTrials.gov registry record
Pharmacogenetics Sampling of the CC-90007-CP-003 Study Cohort
A clinical trial, sponsored by Celgene.
- Completed
- Registry status
- 28
- Enrollment target
NCT04097704 is a clinical trial that has completed, run by Celgene. The registered enrollment target is 28 participants.
The verdict
NCT04097704 has completed, sponsored by Celgene.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
This is a multi-center observational follow-up study to collect saliva samples that allow pharmacogenetic analysis of the subjects that participated in the CC-90007-CP-003 study. Approximately 28 subjects with moderate and severe hepatic impairment and healthy control subjects with normal hepatic function will be enrolled.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2019-09-04 |
| Est. Completion | 2019-11-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04097704
The ClinicalTrials.gov registry entry for NCT04097704 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Celgene, which has 308 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04097704 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04097704 about?
NCT04097704 is a clinical study titled "Pharmacogenetics Sampling of the CC-90007-CP-003 Study Cohort". This is a multi-center observational follow-up study to collect saliva samples that allow pharmacogenetic analysis of the subjects that participated in the CC-90007-CP-003 study. Approximately 28 subjects with moderate and severe hepatic impairment and healthy control subjects with normal hepatic f...
What is the current status of trial NCT04097704?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2019-09-04. Estimated completion is 2019-11-01.
Who is sponsoring clinical trial NCT04097704?
This trial is sponsored by Celgene, which has 308 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.